Deadline. 

the House of Representatives a report containing the results of the study conducted under subsection (a) and recommendations to improve the application and consistency of the requirements under subsections (c) and (d) of section 565 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–4) to support and expe- dite the research and development of medical countermeasures, as applicable. 

(d) PROTECTION OF NATIONAL SECURITY.—The Comptroller Gen- eral of the United States shall conduct the study and issue the assessment and report under this section in a manner that does not compromise national security. 

## SEC. 605. REVIEW OF THE BENEFITS OF GENOMIC ENGINEERING TECH- NOLOGIES AND THEIR POTENTIAL ROLE IN NATIONAL SECURITY. 

(a) MEETING.— 

(1) IN GENERAL.—Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the ‘‘Secretary’’) shall convene a meeting to discuss the potential role advancements in genomic engineering technologies (including genome editing technologies) may have in advancing national health security. Such meeting shall be held in a manner that does not com- promise national security. 

(2) ATTENDEES.—The attendees of the meeting under para- graph (1)— 

(3) TOPICS.—The meeting under paragraph (1) shall include a discussion of— 

(A) shall include— 

(i) representatives from the Office of the Assistant Secretary for Preparedness and Response, the National Institutes of Health, the Centers for Disease Control and Prevention, and the Food and Drug Administra- tion; and 

(ii) representatives from academic, private, and nonprofit entities with expertise in genome engineering technologies, biopharmaceuticals, medicine, or bio- defense, and other relevant stakeholders; and 

(B) may include— 

(i) other representatives from the Department of Health and Human Services, as the Secretary deter- mines appropriate; and 

(ii) representatives from the Department of Home- land Security, the Department of Defense, the Depart- ment of Agriculture, and other departments, as the Secretary may request for the meeting. 

(A) the current state of the science of genomic engineering technologies related to national health security, including— 

(i) medical countermeasure development, including potential efficiencies in the development pathway and detection technologies; and 

(ii) the international and domestic regulation of products utilizing genome editing technologies; and (B) national security implications, including— 

